AlphaFold predicted structure
AASS · Q9UDR5

Mean pLDDT
90.6/ 100
Very high
926 residues
Confidence breakdown
- Very high(≥ 90)77%
- Confident(70–90)18%
- Low(50–70)2%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aminoadipate-semialdehyde synthase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalhyperlysinemia
saccharopinuria
progressive encephalopathy with leukodystrophy due to DECR deficiency
lysosomal storage disease
neurodegenerative disease
Parkinson disease
Alzheimer disease
multiple sclerosis
Dupuytren Contracture
frozen shoulder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Alpha-aminoadipic semialdehyde synthase, mitochondrial
Bifunctional enzyme that catalyzes the first two steps in lysine degradation
AASS · Q9UDR5

Mean pLDDT
90.6/ 100
Very high
926 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0